Please login to the form below
CoStim Pharmaceuticals
This page shows the latest CoStim Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
Novartis enters PD-1 race via CoStim acquisition
Expands presence in cancer immunotherapies. Novartis has reached a deal to acquire US company CoStim Pharmaceuticals, expanding its position in the hot topic of cancer immunotherapy. ... Boston, Massachusetts-based CoStim - which started operations in
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
- Home-based Senior Medical Writer – Med Ed
-
Salary TBC
- Senior Account Manager, Medical Communications, London
-
Excellent package
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
-
Account Director, Medical Education
-
Salary TBC
- Associate Director – Social Healthcare – London
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- EU Head of Business Development and Client Service
-
Exceptional packge and bonus
-
Senior Medical Writer
-
Salary TBC
-
Health Consultant - Brand Comms
-
Competitive Salary
-
Creative/ Medical Writer
-
Circa £35, 000 With Benefits
- Freelance Senior Account Manager / Account Director - Healthcare...
-
£350-400 depending on experience
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Digital Account Director
-
Salary TBC
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Scientific Director – Medical Communications
-
Salary TBC
Subscribe to our email news alerts
- Where next in Alzheimer’s disease R&D?
- McCann Health bolsters European leadership team
- Biogen and Eisai pull plug on Alzheimer’s drug
- Novo uses voucher for speedy answer on oral semaglutide
- Is Orkambi deal close? Vertex meets again today with NHS England
- Amgen, Servier heart failure drug clears trial hurdle
PMHub
Wordbird
Wordbird is a healthcare communications agency with creative, compelling copy at its heart....
Latest intelligence
- Where next in Alzheimer’s disease R&D?
- How past failures and emerging biology are reshaping drug development...
- Brain power: fresh approaches to Alzheimer’s drug discovery
- New alliances are learning from past mistakes and breaking down research barriers...
- Genomics integration: can the NHS rise to the challenge?
- Experts gather to discuss the UK’s genomic landscape...
Quick links
Infographics
